EMD Serono, Inc.

$80$125

Company is a biopharmaceutical company, engaged in the research and development of oncology, therapeutic, and immuno-oncology medicines The company offers Mavenclad tablets and Rebif (interferon beta-1a) subcutaneous injection for neurological and immunological diseases; and GONAL-f (follitropin alfa for injection), Ovidrel PreFilled syringe (choriogonadotropin alfa injection), and Cetrotide (cetrorelix acetate for injection) for the treatment of infertility. It also offers Serostim injection for the treatment of human immunodeficiency virus (HIV); and therapeutic biopharmaceutical products for cancer treatment. In addition, the company provides clinical trials and performance materials manufacturing services

 

Report ID:

UMSE21417

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMSE21417 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, acquisitions, collaborations, and expansions among others
Biography of top management”

To Purchase more than 5 Company Profiles, Check our bundle pricing.

“1. Key Facts of the Company
2. Company Mission
3. Company Value
4. Growth Strategy
5. Key Products & Services Offered
6. Infographic
7. History/Timeline
8. Executive Team
9. SWOT Analysis
10. Recent Development
10.1 Product Launches
10.2 Partnership
10.3 Business Expansions & Investments

Companies Mentioned

“GlaxoSmithKline (GSK)
Accelerated Cure Project for MS
Merck KGaA